HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of
International Ophthalmology Conference
March 10-12, 2025 | Rome, Italy
Aging Eyes: Changes, Disease and Care
Aging Eyes: Changes, Disease and Care
As you get older, your eyes change. Although some issues grow more widespread as you get older, they can afflict anyone at any age. Presbyopia is a condition in which the lens of the eye gets less flexible and less able to thicken as one ages, making it less able to focus on surrounding things. With age, the number of mucous cells in the conjunctiva may decline. Tear production may decline with age, resulting in less tears available to keep the eye's surface wet. Dry eyes are more common in older adults due to both of these changes.
- Preventing and Treating Eye Disease
- Cataract
- Glaucoma
- Age-Related Macular Degeneration
- Diabetic Retinopathy
- Vision Deterioration
- Age Related Eye Conditions
Committee Members
John David Bullock
Wright State University, United States
Edward Charles Kondrot
Healing the Eye Wellness Center, United States
Minckler Don S
UCI Gavin Herbert Eye Institute, United States IOC 2025 Speakers
Dhruva Drew Gupta
Harvard Medical School, United States
Nour Abou Shousha
Harvard Medical School, United States
George HH Beiko
McMaster Univeresity, Canada
Mustafa Al Ghazi
University Hospital of Wales, United KingdomSubmit your abstract Today
Title : Optic nerve orthograde axonal transport in abusive head trauma suspects
Minckler Don S, UCI Gavin Herbert Eye Institute, United States
Title : Eyes and guts connection: Microbiomes and their role in ocular health
Edward Charles Kondrot, Healing the Eye Wellness Center, United States
Title : Why was Leonhard Euler blind?
John David Bullock, Wright State University, United States
Title : Ultra-widefield protocol enhances automated classification of diabetic retinopathy severity with OCT angiography
Kasra Rezaei, University of Washington, United States
Title : A factorial randomized controlled trial of tissue plasminogen activator and/or perfluoropropane for the treatment of submacular hemorrhage secondary to neovascular age-related macular degeneration (TAPAS)
Tim Jackson, King’s College London, United Kingdom
Title : Developing resilience-based treatments for glaucoma
Simon John, Columbia University, United States